MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

People who order the medicine directly from drugmaker Eli Lilly ... pens they get at a local pharmacy. But the move to self-administration with a syringe and needle, just like how insulin is ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

and Eli Lilly's Humalog (insulin lispro) – will be priced at no more than $30 per vial and no more than $55 for a box of five pen cartridges – which Civica says is "a significant discount to ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Wells Fargo analyst Mohit Bansal assigned a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target of ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

Eli Lilly(NYSE:LLY) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a robust 36% surge in Q2 revenue, driven by new product launches ...

Eli Lilly announced positive results from two phase 3 clinical trials (QWINT-1 and QWINT-3), which evaluated a new once-weekly insulin called efsitora alfa (efsitora) for adults with type 2 diabetes.